BRISTOL, Tenn., April 25 /PRNewswire-FirstCall/ -- King
Pharmaceuticals, Inc. (NYSE: KG) reported today that the company plans to
announce financial results for the first quarter ending March 31, 2006,
prior to the market open on Tuesday, May 9, 2006. Conference call
information will be provided when available via a subsequent press release.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions,
of novel branded prescription pharmaceutical products in attractive markets
and the strategic acquisition of branded products that can benefit from
focused promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but
not limited to, statements pertaining to the anticipated date for release
of the Company's financial results for the first quarter ending March 31,
2006. These forward-looking statements involve certain significant risks
and uncertainties, and actual results may differ materially from the
forward- looking statements. An important factor which may cause results to
differ is whether King is able to release the Company's financial results
for first quarter ending March 31, 2006, as currently planned on May 9,
2006. King does not undertake to publicly update or revise any of its
forward-looking statements even if experience or future changes show that
the indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
http://www.prnewswire.com/comp/120319.html /
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
